News
A
145.97
+3.28%
4.63
Onfolio to implement 1-for-50 reverse stock split to regain Nasdaq compliance
Seeking Alpha · 4d ago
Tennant Non-GAAP EPS of $0.83 misses by $0.50, revenue of $324M misses by $5.55M
Seeking Alpha · 4d ago
New EU Ovarian Cancer Diagnostic Approval Could Be A Game Changer For Agilent Technologies (A)
Simply Wall St · 4d ago
Weak Growth In Its Primary Market Continues To Weigh Heavily On Bruker Shares
Seeking Alpha · 4d ago
Solventum to Report Q2 Earnings: What's in Store for the Stock?
NASDAQ · 6d ago
Weekly Report: what happened at A last week (0727-0731)?
Weekly Report · 08/03 09:34
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
NASDAQ · 07/30 21:25
Porch Group GAAP EPS of $0.05 beats by $0.07, revenue of $140.9M beats by $18.6M
Seeking Alpha · 07/29 20:07
Frontier Group Non-GAAP EPS of -$0.10 beats by $0.37, revenue of $1.28B beats by $60M
Seeking Alpha · 07/29 12:04
Humana beats Q2 estimates, affirms guidance
Seeking Alpha · 07/29 10:05
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
Barchart · 07/28 15:15
Agilent Technologies (A) Could Be 14% Undervalued Following FDA Cancer Test Approval
Simply Wall St · 07/28 12:28
Weekly Report: what happened at A last week (0720-0724)?
Weekly Report · 07/27 09:37
Agilent Technologies (A) Is Up 5.4% After New OPDIVO-Linked PD-L1 Test Approval - Has The Bull Case Changed?
Simply Wall St · 07/26 21:21
Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus
Seeking Alpha · 07/26 13:05
Agilent (A) Stock May Be 22% Below Fair Value As HALO Investment Grows
Simply Wall St · 07/25 08:26
Lamb Weston Non-GAAP EPS of $0.87 beats by $0.24, revenue of $1.77B beats by $80M
Seeking Alpha · 07/24 12:03
What to Expect From Agilent Technologies' Q3 2026 Earnings Report
Barchart · 07/24 10:39
1 Healthcare Stock to Research Further and 2 We Avoid
Barchart · 07/24 05:06
Lithium Miners News For The Month Of July 2026
Seeking Alpha · 07/24 02:25
More
Webull provides a variety of real-time A stock news. You can receive the latest news about Agilent Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About A
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.